FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309156659> ?p ?o ?g. }

• W4309156659 endingPage "2534" @default.
• W4309156659 startingPage "2524" @default.
• W4309156659 abstract "Progressive supranuclear palsy is a primary tauopathy affecting both neurons and glia and is responsible for both motor and cognitive symptoms. Recently, it has been suggested that progressive supranuclear palsy tauopathy may spread in the brain from cell to cell in a 'prion-like' manner. However, direct experimental evidence of this phenomenon, and its consequences on brain functions, is still lacking in primates. In this study, we first derived sarkosyl-insoluble tau fractions from post-mortem brains of patients with progressive supranuclear palsy. We also isolated the same fraction from age-matched control brains. Compared to control extracts, the in vitro characterization of progressive supranuclear palsy-tau fractions demonstrated a high seeding activity in P301S-tau expressing cells, displaying after incubation abnormally phosphorylated (AT8- and AT100-positivity), misfolded, filamentous (pentameric formyl thiophene acetic acid positive) and sarkosyl-insoluble tau. We bilaterally injected two male rhesus macaques in the supranigral area with this fraction of progressive supranuclear palsy-tau proteopathic seeds, and two other macaques with the control fraction. The quantitative analysis of kinematic features revealed that progressive supranuclear palsy-tau injected macaques exhibited symptoms suggestive of parkinsonism as early as 6 months after injection, remaining present until euthanasia at 18 months. An object retrieval task showed the progressive appearance of a significant dysexecutive syndrome in progressive supranuclear palsy-tau injected macaques compared to controls. We found AT8-positive staining and 4R-tau inclusions only in progressive supranuclear palsy-tau injected macaques. Characteristic pathological hallmarks of progressive supranuclear palsy, including globose and neurofibrillary tangles, tufted astrocytes and coiled bodies, were found close to the injection sites but also in connected brain regions that are known to be affected in progressive supranuclear palsy (striatum, pallidum, thalamus). Interestingly, while glial AT8-positive lesions were the most frequent near the injection site, we found mainly neuronal inclusions in the remote brain area, consistent with a neuronal transsynaptic spreading of the disease. Our results demonstrate that progressive supranuclear palsy patient-derived tau aggregates can induce motor and behavioural impairments in non-human primates related to the prion-like seeding and spreading of typical pathological progressive supranuclear palsy lesions. This pilot study paves the way for supporting progressive supranuclear palsy-tau injected macaque as a relevant animal model to accelerate drug development targeting this rare and fatal neurodegenerative disease." @default.
• W4309156659 created "2022-11-24" @default.
• W4309156659 creator A5000417123 @default.
• W4309156659 creator A5004190849 @default.
• W4309156659 creator A5005800032 @default.
• W4309156659 creator A5018530098 @default.
• W4309156659 creator A5031560431 @default.
• W4309156659 creator A5033276278 @default.
• W4309156659 creator A5049259662 @default.
• W4309156659 creator A5065552925 @default.
• W4309156659 creator A5075080019 @default.
• W4309156659 creator A5075860164 @default.
• W4309156659 creator A5080522124 @default.
• W4309156659 date "2022-11-16" @default.
• W4309156659 modified "2023-10-01" @default.
• W4309156659 title "Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates" @default.
• W4309156659 cites W1987099665 @default.
• W4309156659 cites W1994147316 @default.
• W4309156659 cites W2018765794 @default.
• W4309156659 cites W2025530880 @default.
• W4309156659 cites W2027660956 @default.
• W4309156659 cites W2032676029 @default.
• W4309156659 cites W2053281391 @default.
• W4309156659 cites W2057682957 @default.
• W4309156659 cites W2081966615 @default.
• W4309156659 cites W2095649828 @default.
• W4309156659 cites W2096321704 @default.
• W4309156659 cites W2099340107 @default.
• W4309156659 cites W2110228168 @default.
• W4309156659 cites W2150797019 @default.
• W4309156659 cites W2167279371 @default.
• W4309156659 cites W2170906442 @default.
• W4309156659 cites W2319874712 @default.
• W4309156659 cites W2473772223 @default.
• W4309156659 cites W2534587007 @default.
• W4309156659 cites W2549361605 @default.
• W4309156659 cites W2563169901 @default.
• W4309156659 cites W2623663856 @default.
• W4309156659 cites W2766057155 @default.
• W4309156659 cites W2803992338 @default.
• W4309156659 cites W2892135048 @default.
• W4309156659 cites W2903559590 @default.
• W4309156659 cites W2950571742 @default.
• W4309156659 cites W2952837230 @default.
• W4309156659 cites W2971759903 @default.
• W4309156659 cites W3022376055 @default.
• W4309156659 cites W3025431232 @default.
• W4309156659 cites W3085451654 @default.
• W4309156659 cites W3135537663 @default.
• W4309156659 cites W3167635709 @default.
• W4309156659 cites W3183664981 @default.
• W4309156659 cites W3193873334 @default.
• W4309156659 cites W3194887163 @default.
• W4309156659 cites W3202815206 @default.
• W4309156659 cites W3206349121 @default.
• W4309156659 cites W4206085863 @default.
• W4309156659 cites W4220753642 @default.
• W4309156659 doi "https://doi.org/10.1093/brain/awac428" @default.
• W4309156659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36382344" @default.
• W4309156659 hasPublicationYear "2022" @default.
• W4309156659 type Work @default.
• W4309156659 citedByCount "1" @default.
• W4309156659 countsByYear W43091566592023 @default.
• W4309156659 crossrefType "journal-article" @default.
• W4309156659 hasAuthorship W4309156659A5000417123 @default.
• W4309156659 hasAuthorship W4309156659A5004190849 @default.
• W4309156659 hasAuthorship W4309156659A5005800032 @default.
• W4309156659 hasAuthorship W4309156659A5018530098 @default.
• W4309156659 hasAuthorship W4309156659A5031560431 @default.
• W4309156659 hasAuthorship W4309156659A5033276278 @default.
• W4309156659 hasAuthorship W4309156659A5049259662 @default.
• W4309156659 hasAuthorship W4309156659A5065552925 @default.
• W4309156659 hasAuthorship W4309156659A5075080019 @default.
• W4309156659 hasAuthorship W4309156659A5075860164 @default.
• W4309156659 hasAuthorship W4309156659A5080522124 @default.
• W4309156659 hasConcept C142724271 @default.
• W4309156659 hasConcept C15744967 @default.
• W4309156659 hasConcept C169760540 @default.
• W4309156659 hasConcept C2776477761 @default.
• W4309156659 hasConcept C2776525014 @default.
• W4309156659 hasConcept C2776925932 @default.
• W4309156659 hasConcept C2776936178 @default.
• W4309156659 hasConcept C2777739294 @default.
• W4309156659 hasConcept C2779134260 @default.
• W4309156659 hasConcept C2781172350 @default.
• W4309156659 hasConcept C71924100 @default.
• W4309156659 hasConceptScore W4309156659C142724271 @default.
• W4309156659 hasConceptScore W4309156659C15744967 @default.
• W4309156659 hasConceptScore W4309156659C169760540 @default.
• W4309156659 hasConceptScore W4309156659C2776477761 @default.
• W4309156659 hasConceptScore W4309156659C2776525014 @default.
• W4309156659 hasConceptScore W4309156659C2776925932 @default.
• W4309156659 hasConceptScore W4309156659C2776936178 @default.
• W4309156659 hasConceptScore W4309156659C2777739294 @default.
• W4309156659 hasConceptScore W4309156659C2779134260 @default.
• W4309156659 hasConceptScore W4309156659C2781172350 @default.
• W4309156659 hasConceptScore W4309156659C71924100 @default.
• W4309156659 hasFunder F4320311904 @default.

• next